Atrial Extracellular Matrix Remodeling and the Maintenance of Atrial Fibrillation

Circulation

Volumn 109, Issue 3, 2004, Pages 363-368

  Xu, Jun ^a   Cui, Guanggen ^a   Esmailian, Fardad ^a   Plunkett, Mark ^a   Marelli, Daniel ^a   Ardehali, Abbas ^a   Odim, Jonah ^a   Laks, Hillel ^a   Sen, Luyi ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UCLA MEDICAL CENTER   (United States)

Author keywords

Atrium; Collagen; Fibrillation; Heart failure; Metalloproteinases

Indexed keywords

ANGIOTENSIN ANTAGONIST; COLLAGEN TYPE 1; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GELATINASE A; SPIRONOLACTONE; TISSUE INHIBITOR OF METALLOPROTEINASE 2;

ADULT; ARTICLE; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; CORRELATION ANALYSIS; DOWN REGULATION; EXTRACELLULAR MATRIX; FEMALE; HEART ATRIUM; HEART ATRIUM FIBRILLATION; HEART FAILURE; HEART MUSCLE CELL; HEART TRANSPLANTATION; HEART VENTRICLE REMODELING; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; UPREGULATION; WESTERN BLOTTING;

ATRIAL FIBRILLATION; COLLAGEN TYPE I; COLLAGEN TYPE III; EXTRACELLULAR MATRIX; FEMALE; GELATINASES; HEART ATRIA; HUMANS; MALE; MATRIX METALLOPROTEINASES; MIDDLE AGED; TISSUE INHIBITOR OF METALLOPROTEINASES;

EID: 1642540007     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.0000109495.02213.52     Document Type: Article

References (25)

1. Frustaci A, Chimenti C, Bellocci F, et al. Histological substrate of atrial biopsies in patients with lone atrial fibrillation. Circulation. 1997;96:1180-1184.
2. Van der Velden HM, van Kempen MJ, Wijffels MC, et al. Altered pattern of connexin40 distribution in persistent atrial fibrillation in the goat. J Cardiovasc Electrophysiol. 1998;9:596-607.
3. Ausma J, Dispersyn GD, Duimel H, et al. Changes in ultrastructural calcium distribution in goat atria during atrial fibrillation. J Mol Cell Cardiol. 2000;32:355-364.
4. Sackner-Bernstein JD. The myocardial matrix and the development and progression of ventricular remodeling. Curr Cardiol Rep. 2000;2:112-119.
5. Weber KT. Cardiac interstitium in health and disease: the fibrillar collagen network. J Am Coll Cardiol. 1989;13:1637-1652.
6. Bellet S. Atrial fibrillation (clinical manifestations). In: Clinical Disorders of the Heartbeat. Philadelphia: Lea and Febiger; 1971;223-233.
7. Gallagher MM, Camm J. Classification of atrial fibrillation. Am J Cardiol. 1998;82:18N-28N.
8. Spinale FG. Matrix metalloproteinases: regulation and dysregulation in the failing heart. Circ Res. 2002;90:520-530.
9. Ausma J, van der Velden HM, Lenders MH, et al. Reverse structural and gap-junctional remodeling after prolonged atrial fibrillation in the goat. Circulation. 2003;107:2051-2058.
10. Allessie M, Ausma J, Schotten U. Electrical, contractile and structural remodeling during atrial fibrillation. Cardiovasc Res. 2002;54:230-246.
11. Boyden PA, Tilley LP, Pham TD, et al. Effects of left atrial enlargement on atrial transmembrane potentials and structural in dogs with mitral valve fibrosis. Am J Cardiol. 1982;49:1896-1908.
12. Boyden PA, Tilley LP, Albala A, et al. Mechanisms for atrial arrhythmias associated with cardiomyopathy: a study of feline hearts with primary myocardial disease. Circulation. 1984;69:1036-1047.
13. Li D, Fareh S, Leung TK, et al. Promotion of atrial fibrillation by heart failure in dogs: atrial remodeling of a different sort. Circulation. 1999;100:87-95.
14. Kostin S, Klein G, Szalay Z, et al. Structural correlate of atrial fibrillation in human patients. Cardiovasc Res. 2002;54:361-379.
15. Shinagawa K, Shi Y-F, Tardif J-C, et al. Dynamic nature of atrial fibrillation substrate during development and reversal of heart failure in dogs. Circulation 2002;105:2672-2678.
16. Miyauchi Y, Zhou S, Okuyama Y, et al. Altered atrial electrical restitution and heterogeneous sympathetic hyperinnervation in hearts with chronic left ventricular myocardial infarction: implications for atrial fibrillation. Circulation. 2003;108:360-366.
17. Pauschinger M, Doerner A, Remppis A, et al. Differential myocardial abundance of collagen type I and type III mRNA in dilated cardiomyopathy: effects of myocardial inflammation. Cardiovasc Res. 1998;37:123-129.
18. Carver W, Nagpal ML, Nachtigal M, et al. Collagen expression in mechanically stimulated cardiac fibroblasts. Circ Res. 1991;69:116-122.
19. Goette A, Arndt M, Rocken C, et al. Regulation of angiotensin II receptor subtypes during atrial fibrillation in humans. Circulation. 2000;101:2678-2681.
20. Shi Y, Li D, Tardif J, et al. Enalapril effects on atrial remodeling and atrial fibrillation in experimental congestive heart failure. Cardiovasc Res. 2002;54:456-461.
21. Thomas CV, Coker ML, Zellner JL, et al. Increased matrix metalloproteinase activity and selective upregulation in LV myocardium from patients with end-stage dilated cardiomyopathy. Circulation. 1998;97:1708-1715.
22. Li YY, Feldman AM, Sun Y, et al. Differential expression of tissue inhibitors of metalloproteinases in the failing human heart. Circulation. 1998;98:1728-1734.
23. Spinale FG, Coker ML, Heung LJ, et al. A matrix metalloproteinase induction/activation system exists in the human left ventricular myocardium and is upregulated in heart failure. Circulation. 2000;102:1944-1949.
24. Ritty TM, Herzog J. Tendon cells produce gelatinases in response to type 1 collagen attachment. J Orthop Res. 2003;21:442-450.
25. Li YY, Feng Y, McTiernan CF, et al. Downregulation of matrix metalloproteinases and reduction in collagen damage in the failing human heart after support with left ventricular assist devices. Circulation. 2001;104:1147-1152.